ArticleBMC infectious diseases2025
Prevalence and associated risk factors of Staphylococcus aureus nasal colonization among a cohort of immunocompromised individuals in Lagos, Nigeria.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImmunocompromised individuals are highly vulnerable to Staphylococcus aureus (S. aureus) infections, leading to increased morbidity and mortality. This study aimed to assess the prevalence, virulence, and risk factors associated with S. aureus nasal carriage among immunocompromised individuals in Lagos, Nigeria.
methodsA total of 350 participants were enrolled, including 150 HIV/AIDS cases, 50 HIV/TB co-infections, 100 diabetes cases, and 50 controls. Nasal swabs were collected and cultured on Mannitol salt agar for the isolation of Staphylococcus aureus. Presumptive isolates were confirmed using Gram staining, catalase, and coagulase tests. Antimicrobial susceptibility was determined using the Kirby-Bauer disk diffusion method in accordance with CLSI guidelines. Molecular detection of resistance and virulence genes was performed using PCR targeting the mecA gene (methicillin resistance) and pvl (Panton-Valentine leukocidin). A structured questionnaire capturing clinical history and hygiene practices was used to evaluate risk factors for S. aureus carriage.
resultsThe overall prevalence of S. aureus was 14.6% (51/350), S. aureus was isolated in 28% (14/50) of controls, 16.7% (25/150) of HIV/AIDS patients, 14% (7/50) of HIV/TB cases and 5% (5/100) of diabetes cases. Susceptibility to erythromycin was 80.4%, gentamycin, ciprofloxacin and Sulfamethoxazole-Trimethoprim (64.7%) among all S. aureus isolated. Methicillin-resistant S. aureus (MRSA) was detected in 78.4% (40/51) of isolates, predominantly among HIV/AIDS patients (52.5%). pvl genes were identified in 11.8% (6/51) of isolates. S. aureus carriage was significantly associated with recent antibiotic use (p = 0.003) and contact with animals (p = 0.018).
conclusionThis study demonstrates a high prevalence of S. aureus among controls compared to immunocompromised individuals. These results highlight the need for further studies to elucidate the relationship between host factors and S. aureus colonization. This could inform targeted strategies for infection prevention and control. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.